Rivaroxaban as Safe and Effective as Standard Therapy in Japanese DVT Patients: J-EINSTEIN DVT Study

The results of the J-EINSTEIN DVT study, which investigated the benefits of rivaroxaban monotherapy in Japanese patients with acute symptomatic deep vein thrombosis (DVT), were announced on September 26 during the 62nd Scientific Session of the Japanese College of Cardiology...read more